Canadian school-based HPV vaccine programs and policy considerations |
| |
| Institution: | 1. Department of Psychology, McGill University, Montreal, Quebec, Canada;2. Centre for Health Policy, School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia;3. Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada;1. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, 171 77 Stockholm, Sweden;2. Department of Laboratory Medicine, Karolinska Institutet, Alfred Nobels Allé 8, 141 83 Stockholm, Sweden;1. Public Health Ontario, Toronto, ON, Canada;2. Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada;3. Immunization Policy and Programs, Ontario Ministry of Health and Long-Term Care, Toronto, ON, Canada;1. Department of Psychology, McGill University, Montreal, Quebec H3A 1B1, Canada;2. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec H3T 1E2, Canada;3. Department of Education, Child and School Psychology Program, Hebrew University, Jerusalem, 9190501, Israel;4. Louise Granofsky Psychosocial Oncology Program, Segal Cancer Center, Jewish General Hospital, Montreal, Quebec H3T 1E2, Canada;5. Departments of Oncology and Psychiatry, McGill University, Montreal, Quebec H4A 3T2, Canada;1. Public Health Ontario, 480 University Avenue, Suite 300, Toronto, ON M5G 1V2, Canada;2. Dalla Lana School of Public Health, University of Toronto, 155 College St, Toronto, ON M5T 3M7, Canada;3. Institute for Clinical Evaluative Sciences, Veterans Hill Trail, 2075 Bayview Avenue G106, Toronto, ON M4N 3M5, Canada;4. Department of Family and Community Medicine, University of Toronto, 500 University Ave, Toronto, ON M5G 1V7, Canada;5. Women’s College Hospital and Women’s College Research Institute, 790 Bay St, Toronto, ON M5G 1N8, Canada;1. Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada;2. Department of Electrical and Computer Engineering, University of Manitoba, Winnipeg, Manitoba, Canada;3. Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada;4. Health Workforce Strategies, Manitoba Health, Winnipeg, Manitoba, Canada;5. Sydney School of Public Heath, University of Sydney, Sydney, NSW, Australia;6. Cancer Research Division, Cancer Council NSW, Woolloomooloo, Australia;7. Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, Manitoba, Canada;8. Cancer Control Research, British Columbia Cancer Agency, Vancouver, British Columbia, Canada |
| |
| Abstract: | BackgroundThe National Advisory Committee on Immunization in Canada recommends human papillomavirus (HPV) vaccination for females and males (ages 9–26). In Canada, the HPV vaccine is predominantly administered through publicly funded school-based programs in provinces and territories. This research provides an overview of Canadian provincial and territorial school-based HPV vaccination program administration and vaccination rates, and identifies foreseeable policy considerations.MethodsWe searched the academic and grey literature and contacted administrators of provincial and territorial vaccination programs to compile information regarding HPV vaccine program administration and vaccination rates in Canada’s 13 provincial and territorial jurisdictions.ResultsAs of October 2016, all 13 Canadian jurisdictions vaccinate girls, and six jurisdictions include boys in school-based publicly funded HPV vaccination programs. Eleven jurisdictions administer the HPV vaccine in a two-dose schedule. The quadrivalent vaccine (HPV4) has been the vaccine predominantly used in Canada; however, the majority of provinces will likely adopt the nonavalent vaccine in the future. According to available data, vaccination uptake among females ranged between 46.7% and 93.9%, while vaccination uptake among males (in programs with available data to date) ranged between 75.0% and 87.4%.ConclusionsFuture research and innovation will beneficially inform Canadian jurisdictions when considering whether to administer the nonavalent vaccine, whether to implement a two or one-dose vaccination schedule, and how to improve uptake and rates of completion. The usefulness of standardizing methodologies for collecting and reporting HPV vaccination coverage and implementing a national registry were identified as important priorities. |
| |
| Keywords: | Canada Cancer prevention Human papillomavirus Immunization policy School-based vaccination programs Vaccination coverage |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
